scispace - formally typeset
C

Caixia Xia

Researcher at Zhejiang University

Publications -  17
Citations -  287

Caixia Xia is an academic researcher from Zhejiang University. The author has contributed to research in topics: Hepatitis B & Cirrhosis. The author has an hindex of 6, co-authored 14 publications receiving 155 citations. Previous affiliations of Caixia Xia include Nanjing Medical University.

Papers
More filters
Journal ArticleDOI

MiR-199a-modified exosomes from adipose tissue-derived mesenchymal stem cells improve hepatocellular carcinoma chemosensitivity through mTOR pathway

Guohua Lou, +9 more
- 02 Jan 2020 - 
TL;DR: AMSC-Exo- 199a can be an effective vehicle for miR-199a delivery, and they effectively sensitized HCC to chemotherapeutic agents by targeting mTOR pathway and subsequently inhibiting the m TOR pathway.
Journal ArticleDOI

Involvement of Interleukin 6 in Hepatitis B Viral Infection.

Caixia Xia, +3 more
- 01 Jan 2015 - 
TL;DR: This review aims to present the latest discoveries concerning the role of IL-6 in hepatitis B disease progression, and HBV entry and replication, and evaluate polymorphisms that are associated with the development of hepatitis B Disease.
Journal ArticleDOI

Direct targeting sperm-associated antigen 9 by miR-141 influences hepatocellular carcinoma cell growth and metastasis via JNK pathway.

Guohua Lou, +10 more
- 21 Jan 2016 - 
TL;DR: MiR-141 suppression may cause aberrant expression of SPAG9 and promote HCC tumorigenesis via JNK pathway and dual-luciferase reporter assay showed that SPAg9 was a direct target gene of miR- 141.
Journal ArticleDOI

Isoliquiritigenin Inhibits Interferon-γ-Inducible Genes Expression in Hepatocytes through Down-Regulating Activation of JAK1/STAT1, IRF3/MyD88, ERK/MAPK, JNK/MAPK and PI3K/Akt Signaling Pathways.

Shanshan Wu, +12 more
- 01 Jan 2015 - 
TL;DR: It is demonstrated that ISL inhibits IFN-γ-induced inflammation in hepatocytes via influencing the activation of JAK1/STAT1, IRF3/MyD88, ERK/ MAPK, JNK/MAPK, and PI3K/Akt signaling pathways.
Journal ArticleDOI

0404 inhibits hepatocellular carcinoma through a p53/miR-34a/SIRT1 positive feedback loop.

Caixia Xia, +13 more
- 30 Jun 2017 - 
TL;DR: The findings show that 0404 is probably an attractive agent for treating HCC, especially in HCC with wide type (WT) p53, through forming a p53/miR-34a/SIRT1 signal feedback loop to promote cell apoptosis.